|
|
International Clinical Trials
|
As life expectancy rises and clinical investigations and treatments get ever more effective and complex, expectations of what health systems should deliver in terms of keeping people healthy for longer are, rightly, growing. However, the longstanding challenges of wide variation in access and quality, even within a single system, and spiralling costs are putting an ever greater strain on health systems and pose a risk to continued progress.
Today, healthcare quality is mainly understood in terms of process measures, such as waiting times, length of stay, and discharge rates as well as the unintended consequences or complications of care, such as hospital acquired infections and mortality. These measures are clearly important and need to be measured and managed, but they do not help patients or clinicians understand the actual results of care from the perspective of the patient. This includes information about which patients get better or worse or in what circumstances treatment is successful, whether it is generally done at the right time by a particular doctor or hospital and, if not, why not, how long the benefits last or the relative successes between treatments, doctors, and hospitals. The International Consortium of Health Outcomes Measurement (ICHOM) define ‘outcomes’ as: “The results people care about most when seeking treatment, including functional improvement and the ability to live normal, productive lives” (1). ICHOM was established in 2014 as a partnership between Harvard Business School, Boston Consulting Group, and the Karolinska Institutet in Sweden to set a global standard for outcomes measurement at the level of the clinical condition.
|
Read full article from PDF >>
|
 |
 |
 |
Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | |
|
|
As life expectancy rises and clinical investigations and treatments get
ever more effective and complex, expectations of what health systems
should deliver in terms of keeping people healthy for longer are,
rightly, growing. However, the longstanding challenges of wide variation
in access and quality, even within a single system, and spiralling
costs are putting an ever greater strain on health systems and pose a
risk to continued progress.
Today, healthcare quality is mainly
understood in terms of process measures, such as waiting times, length
of stay, and discharge rates as well as the unintended consequences or
complications of care, such as hospital acquired infections and
mortality. These measures are clearly important and need to be measured
and managed, but they do not help patients or clinicians understand the
actual results of care from the perspective of the patient. This
includes information about which patients get better or worse or in what
circumstances treatment is successful, whether it is generally done at
the right time by a particular doctor or hospital and, if not, why not,
how long the benefits last or the relative successes between treatments,
doctors, and hospitals. The International Consortium of Health Outcomes
Measurement (ICHOM) define ‘outcomes’ as: “The results people care
about most when seeking treatment, including functional improvement and
the ability to live normal, productive lives” (1). ICHOM was established
in 2014 as a partnership between Harvard Business School, Boston
Consulting Group, and the Karolinska Institutet in Sweden to set a
global standard for outcomes measurement at the level of the clinical
condition.
|
|
 |
 |
 |
|
 |
News and Press Releases |
 |
Live from Pharmapack: Pharmapack Drug Delivery Index hits record high
More info >> |
|

 |
White Papers |
 |
Considerations for Choosing the Right Wearable Drug Delivery System
West Pharmaceutical Services, Inc.
For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >> |
|
|